$600 a month to lose weight. Migraine drugs that are nigh impossible to get at any price. The market for pharmaceutical products in Australia is all topsy-turvy, and it’s part red-tape nightmare, part geopolitical standoff. Our health editor Natasha Robinson has been investigating what’s going wrong, and she’s here in just a moment to diagnose the real problem.

Read more about this story at theaustralian.com.au and see the video by subscribing to our YouTube channel.

Mounjaro rejection explains why our access to cheaper medicines if failing

Australian patients risk losing lifesaving medicines amid pharmaceutical subsidy crisis

Australia’s drug approval system faces reckoning as patients await reform

New-gen medicines are available for migraine and arthritis – but only if you fail the old drugs

This episode of The Front is presented by Claire Harvey, produced by Kristen Amiet and edited by Jasper Leak, who also composed our music. Our team includes Lia Tsamoglou, Tiffany Dimmack, and Joshua Burton.

See omnystudio.com/listener for privacy information.